论文部分内容阅读
【正】 Hubei Biocause Pharmaceutical Co.,Ltd. (Biocause,SZ:000627)announced on October 27th to invest RMB302 million in buildinga new propylene project.The proposed propylene project is to offer propylene to its20 000 t/a polypropylene facility,aiming at ens